3351 - 3360 of 8580 Results
Title
Year
-
OPENTitle: Molecular Insight into Amyloid Fibril-Templated Aggregation of BiomarkersJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 16Issue #: 11Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1021/acschemneuro.5c00103Best OA location URL: https://pubs.acs.org/doi/pdf/10.1021/acschemneuro.5c00103Citation Count: 0
-
OPENTitle: Efficacy of Nilotinib in Patients With Moderately Advanced Parkinson DiseaseJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 78Issue #: 3Start Page: 312End Page: 312Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1001/jamaneurol.2020.4725Best OA location URL: https://jamanetwork.com/journals/jamaneurology/articlepdf/2773698/jamaneurology_simuni_2020_oi_200091_1614894403.37383.pdfCitation Count: 111
- Lack of interleukin-13 receptor α1 delays the loss of dopaminergic neurons during chronic stress2017OPENTitle: Lack of interleukin-13 receptor α1 delays the loss of dopaminergic neurons during chronic stressJournal Name: Journal of NeuroinflammationPublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12974-017-0862-1Best OA location URL: https://jneuroinflammation.biomedcentral.com/track/pdf/10.1186/s12974-017-0862-1Citation Count: 30
-
OPENTitle: Evaluating motor progression of juvenile-onset Huntington's Disease: An Enroll-HD analysisJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 119Issue #:Start Page: 105954End Page: 105954Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2023.105954Best OA location URL: https://doi.org/10.1016/j.parkreldis.2023.105954Citation Count: 1
- A Modified Reading the Mind in the Eyes Test Predicts Behavioral Variant Frontotemporal Dementia Better Than Executive Function Tests2018OPENTitle: A Modified Reading the Mind in the Eyes Test Predicts Behavioral Variant Frontotemporal Dementia Better Than Executive Function TestsJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 10Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2018.00011Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2018.00011/pdfCitation Count: 40
- Identifying individuals at-risk of developing Parkinson’s disease using a population-based recruitment strategy: The Healthy Brain Ageing Kassel Study2025OPENTitle: Identifying individuals at-risk of developing Parkinson’s disease using a population-based recruitment strategy: The Healthy Brain Ageing Kassel StudyJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-025-01008-wCitation Count: 0
- Deep brain stimulation has state-dependent effects on motor connectivity in Parkinson’s disease2019OPENTitle: Deep brain stimulation has state-dependent effects on motor connectivity in Parkinson’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 142Issue #: 8Start Page: 2417End Page: 2431Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awz164Best OA location URL: https://academic.oup.com/brain/article-pdf/142/8/2417/32742258/awz164.pdfCitation Count: 51
-
OPENTitle: Application of texture analysis to DAT SPECT imaging: Relationship to clinical assessmentsJournal Name: NeuroImage: ClinicalPublisher: Elsevier BVVol: 12Issue #:Start Page: e1End Page: e9Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.nicl.2016.02.012Best OA location URL: https://doi.org/10.1016/j.nicl.2016.02.012Citation Count: 72
- Combined fenobam and amantadine treatment promotes robust antidyskinetic effects in the 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)‐lesioned primate model of Parkinson's disease2014RESTRICTEDTitle: Combined fenobam and amantadine treatment promotes robust antidyskinetic effects in the 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)‐lesioned primate model of Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 29Issue #: 6Start Page: 772End Page: 779Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.25859Citation Count: 39
-
OPENTitle: CSF Aβ42 and tau in Parkinson's disease with cognitive impairmentJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: 15Start Page: 2682End Page: 2685Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23287Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/2978754Citation Count: 173